Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.
Melanie Sheen, MD, describes efforts to boost diverse clinical trial enrollment through trust, community partnerships, and ...
A NEW, single-dose malaria treatment combining four existing drugs has been found to be as effective as the standard three-day regimen, offering a potential breakthrough against one of Africa’s ...
Below are examples of poster presentations developed by Research Experiences for Teacher fellows in the 2025 program. These posters highlight learning objectives and the curriculum units developed: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback